remifentanil and kn 93
remifentanil has been researched along with kn 93 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cheng, C; Gu, X; Jiang, M; Ma, Z; Zhang, W | 1 |
| Chen, L; Chen, Z; Gao, X; Li, Z; Lin, C; Liu, T; Qi, F; Tang, H; Wang, L; Wang, ZJ; Zhang, X | 1 |
Other Studies
2 other study(ies) available for remifentanil and kn 93
| Article | Year |
|---|---|
Intrathecal injection of KN93 attenuates paradoxical remifentanil-induced postoperative hyperalgesia by inhibiting spinal CaMKII phosphorylation in rats.
Topics: Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Dose-Response Relationship, Drug; Hyperalgesia; Injections, Spinal; Male; Pain, Postoperative; Piperidines; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Remifentanil; Spinal Cord; Sulfonamides | 2015 |
Ketamine reduces remifentanil-induced postoperative hyperalgesia mediated by CaMKII-NMDAR in the primary somatosensory cerebral cortex region in mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Analgesics; Analgesics, Opioid; Animals; Benzylamines; Blotting, Western; Calcium Channel Agonists; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Fluorescent Antibody Technique; Hyperalgesia; Ketamine; Mice; Pain Threshold; Pain, Postoperative; Postoperative Complications; Protein Kinase Inhibitors; Receptors, N-Methyl-D-Aspartate; Remifentanil; Somatosensory Cortex; Sulfonamides | 2020 |